Skip to main content
. 2022 Dec 16;13(4):705–710. doi: 10.25259/JNRP_11_2022

Table 2:

Distribution of nerve and musculoskeletal complications among the participants (n = 370)*.

Low back pain 52 (14.05)
Degenerative disk disease 35 (9.46)
Lumbar spinal stenosis 21 (5.68)
Spondylolisthesis 9 (2.43)
Others 11 (2.97)
Shoulder pain 41 (11.08)
Periarthritis shoulder 27 (7.30)
Rotator cuff pathology 11 (2.97)
AC joint arthropathy 7 (1.89)
Others 9 (2.43)
Neck pain 26 (7.03)
Degenerative disk disease 19 (5.13)
Spinal canal stenosis 10 (2.70)
Others 8 (2.16)
Knee pain 25 (6.76)
Osteoarthritis knee 21 (5.68)
Pes anserinus bursitis 7 (1.89)
Others 10 (2.70)
Hand and wrist complications 20 (5.40)
Carpal tunnel syndrome 11 (2.97)
Flexor tenosynovitis 9 (2.43)
De Quervain’s tenosynovitis 7 (1.89)
Dupuytren’s contracture 5 (1.35)
Diabetic cheiroarthropathy 4 (1.08)
Others 5 (1.35)
Foot complications 25 (6.76)
Diabetic foot 15 (4.05)
Plantar fasciitis 9 (2.43)
Others 6 (1.62)
Diabetic polyneuropathy 13 (3.51)
Distal symmetrical polyneuropathy 8 (2.16)
Mononeuropathy 5 (1.08)
Polyarthralgia 8 (2.16)
Elbow pain 3 (0.81)
Lateral and medial epicondylosis 3 (0.81)

Data are presented as n (%); *more than 1 complication may coexist